Dopaminergic-Related
Dopaminergic-Related Inhibitors |
|
|---|---|
| Cat. No. | Product Name / Activity |
| 0767 | Bifemelane hydrochloride |
| MAO-A and MAO-B inhibitor | |
| 0455 | (S)-(-)-Carbidopa |
| Aromatic L-amino acid decarboxylase inhibitor | |
| 2460 | Lazabemide hydrochloride |
| Selective MAO-B inhibitor | |
| 4395 | Moclobemide |
| Reversible MAO-A inhibitor | |
| 0483 | OR-486 |
| COMT inhibitor | |
| 4308 | Rasagiline mesylate |
| Selective, irreversible MAO-B inhibitor | |
Other |
|
| Cat. No. | Product Name / Activity |
| 2813 | D-Amphetamine sulfate |
| Induces dopamine, 5-HT and noradrenalin release; also α7 nAChR antagonist | |
| 2547 | 6-Hydroxydopamine hydrobromide |
| Selective catecholaminergic neurotoxin | |
| 1811 | Modafinil |
| Psychostimulant | |
| 2599 | OSU 6162 hydrochloride |
| Dopamine stabilizer | |
Dopamine Scientific Review
Our Dopamine receptors review gives an overview of the dopamine receptor subtypes, and the receptor agonists and antagonists used to study them.
Request copyRequest PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF